Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 25, 2019 1:16pm
106 Views
Post# 29670249

RE:ccabbott what is date they will use to calculate the number

RE:ccabbott what is date they will use to calculate the number
edrose wrote: of shres an investors have  and lot of people sold off shares after april 15th since afraid of clulow's greed   
clulow could only convert eg/ 100 million tell consonance they will put in lesser amount and let retail investors put in more than 75 million which would be fair  but NO CLULOW'S GREED AND CONTROL  
THEIR BEHAVIOUR TELLS OF EVERYTHING I DON'T CARE ABOUT THE RETAIL INVESTORS IT'S ALL ABOUT ME MYSLEF AND I  


edrose I don't know which date is the Record date as the company has not confirmed it in their recent PRs (April 15 and April 23).

The only thing we know so far is that

1. the rights offer will commence in May.

2. It's not SALP's current intention to take part in the rights offer.

I don't think that Consonance will take part either. 

Therefore the original estimate of between 6.7 to 20 is probably correct, depending on how fully the eligible 736 M shares subscribe.
Bullboard Posts